XM अमेरिका के निवासियों को अपनी सेवाएँ मुहैया नहीं करता है।
A
A

Assurant


समाचार

U.S. STOCKS BorgWarner, Digital Realty, Take-Two

BUZZ-U.S. STOCKS ON THE MOVE-BorgWarner, Digital Realty, Take-Two Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes added to their gains on Thursday in the run-up to the Federal Reserve's interest-rate decision, extending a sharp rally sparked by Donald Trump's stunning comeback as U.S.
G
H
J
M
M
N
D
T
U
U
B
L
V
A
B
C
M

U.S. STOCKS Ralph Lauren, CoreCivic, WK Kellogg

BUZZ-U.S. STOCKS ON THE MOVE-Ralph Lauren, CoreCivic, WK Kellogg Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes held on to their gains on Thursday in the run-up to the Federal Reserve's interest-rate decision, extending a sharp rally sparked by Donald Trump's stunning comeback as U.S.
G
H
J
K
M
D
U
U
B
M
V
A
C
M

U.S. STOCKS Guardant Health, AppLovin, Sarepta

BUZZ-U.S. STOCKS ON THE MOVE-Guardant Health, AppLovin, Sarepta Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The S&P 500 and the Nasdaq were set to open higher in the run-up to an interest-rate decision from the Federal Reserve on Thursday, extending a sharp rally sparked by Donald Trump's stunning comeback as U.S.
G
H
J
M
U
U
B
V
A
C
M

Brokerage Truist raises PT on Assurant post a positive Q3

BUZZ-Brokerage Truist raises PT on Assurant post a positive Q3 ** Brokerage Truist Securities raises price target on insurer Assurant AIZ.N post results ** Truist raises PT to $240 from $220 and also raises full-year 2024 EPS estimate to $15 from an earlier $13.45, citing an upside in Q3 and lower assumed losses from Hurricane Milton ** Analysts pr
U
A

U.S. BXP, Hubspot, Qualcomm

U.S. RESEARCH ROUNDUP-BXP, Hubspot, Qualcomm Nov 7 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including BXP, Hubspot and Qualcomm, on Thursday. HIGHLIGHTS * Aspen Technology Inc AZPN.O : Berenberg cuts to hold from buy * BXP Inc BXP.N : Scotiabank cuts to sector perform from sector outperform * Clearwater Analytics Holdings Inc CWAN.N : JP Morgan raises to overweight from neutral * Hubspot Inc HUBS.N : JP Morgan raises ta
A
C
G
D
L
A
A
C
I

Assurant beats third-quarter profit estimates on Global Housing unit growth

Assurant beats third-quarter profit estimates on Global Housing unit growth Nov 5 (Reuters) - Insurer Assurant AIZ.N reported a better-than-expected third-quarter profit on Tuesday, driven by growth in its global housing segment and higher investment returns. The company's global housing unit, which offers lender-placed homeowners, manufactured housing and flood insurance, posted net earned premiums, fees and other income of $603.8 million, a 9% jump from the previous year.
U
A

Assurant Q3 Adjusted EPS USD 3 Vs. IBES Estimate USD 2.52

BRIEF-Assurant Q3 Adjusted EPS USD 3 Vs. IBES Estimate USD 2.52 Nov 05 (Reuters) - Assurant Q3 adjusted EBITDA USD 246.9 million. Q3 EPS USD 2.55 Q3 net income USD 133.8 million
A

Assurant Announces Comprehensive Heavy Truck Extended Service Contract

BRIEF-Assurant Announces Comprehensive Heavy Truck Extended Service Contract Oct 30 (Reuters) - Assurant Inc AIZ.N : ASSURANT ANNOUNCES COMPREHENSIVE HEAVY TRUCK EXTENDED SERVICE CONTRACT Source text: ID:nBw3kSWjja Further company coverage: AIZ.N
A

Assurant Inc - Hurricane Milton Is Expected To Be A Reportable Catastrophe For Q4 2024

BRIEF-Assurant Inc - Hurricane Milton Is Expected To Be A Reportable Catastrophe For Q4 2024 Oct 16 (Reuters) - Assurant Inc AIZ.N : ASSURANT INC - HURRICANE MILTON IS EXPECTED TO BE A REPORTABLE CATASTROPHE FOR Q4 2024 ASSURANT INC: EXPECTS ABOUT $138 MILLION PRE-TAX, OR $109 MILLION AFTER-TAX OF REPORTABLE CATASTROPHES FOR Q3 2024 Source text for
A

S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT S&P 500 .SPX Top Performers Percent Change Super Micro Computer Inc SMCI.OQ +15.5% Air Products and Chemicals Inc APD.N +9.3% Generac Holdings Inc GNRC.N +8.9% Albemarle Corp ALB.N +2.9% Diamondback Energy Inc FANG.OQ +2.8% Bottom Performers Percent Change Everest Group Ltd EG.
U
A
D
G
A

US property and casualty insurers' shares slump as hurricane season losses mount

UPDATE 2-US property and casualty insurers' shares slump as hurricane season losses mount Property and casualty insurance stocks slump on Hurricane Milton-related fears Another catastrophe adds to insurers' Florida woes Analysts say the full extent of hurricane season damage still unknown Adds Generac's stock performance in paragraph 14; Updates prices throughout By Manya Saini Oct 7 (Reuters) - U.S.
G
A

US property and casualty insurers slump as hurricane season brings losses

US property and casualty insurers slump as hurricane season brings losses Property and casualty insurance stocks slump on Hurricane Milton-related fears Another catastrophe adds to insurers' Florida woes Analysts say the full extent of hurricane season damage still unknown By Manya Saini Oct 7 (Reuters) - U.S. property and casualty insurance stocks tanked on Monday after Hurricane Milton intensified into a category 4 on its path toward Florida's western coast, marking yet another costly disaster
A

S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT S&P 500 .SPX Top Performers Percent Change Super Micro Computer Inc SMCI.OQ +14.9% Air Products and Chemicals Inc APD.N +7.6% Generac Holdings Inc GNRC.N +7.5% NVIDIA Corp NVDA.OQ +3.4% Pfizer Inc PFE.N +3.0% Bottom Performers Percent Change Everest Group Ltd EG.N -7.8% Deckers
N
P
U
A
G
A

U.S. Aadi Bioscience, Target, Visteon

U.S. RESEARCH ROUNDUP-Aadi Bioscience, Target, Visteon Aug 22 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Aadi Bioscience, Target and Visteon, on Thursday. HIGHLIGHTS * Aadi Bioscience Inc AADI.O : Jefferies cuts to hold from buy * Assurant Inc AIZ.N : Piper Sandler cuts to neutral from overweight * Estée Lauder EL.N : Piper Sandler raises to overweight from neutral * Target Corp TGT.N : Jefferies raises target
A
A
H
S
T
T
U
A
P
U
D
E
A

U.S. Agenus, Guardant Health, Zoetis

U.S. RESEARCH ROUNDUP-Agenus, Guardant Health, Zoetis Aug 14 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Agenus, Guardant Health and Zoetis, on Wednesday. HIGHLIGHTS * Agenus Inc AGEN.O : B. Riley cuts target price to $18 from $42 * Clorox CLX.N : Jefferies raises target price to $151 from $148 * Guardant Health Inc GH.O : Raymond James raises target price to $36 from $28 * Starbucks SBUX.O : Stifel raises to buy
A
C
D
E
I
E
A
A
C
E

U.S. Apollo, Blackstone, Hershey

U.S. RESEARCH ROUNDUP- Apollo, Blackstone, Hershey Aug 13 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Apollo, Blackstone and Hershey, on Tuesday. HIGHLIGHTS * Apollo APO.N : Jefferies cuts target price to $114 from $129 * Blackstone BX.N : Jefferies raises target price to $147 from $138 * Hershey Co HSY.N : Goldman Sachs initiates coverage with sell rating * Palomar Holdings Inc PLMR.O : KBW raises target price to
A
A
A
A

U.S. Amphastar Pharmaceuticals, G1 Therapeutics, Upwork

U.S. RESEARCH ROUNDUP-Amphastar Pharmaceuticals, G1 Therapeutics, Upwork Aug 8 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Amphastar Pharmaceuticals, G1 Therapeutics and Upwork on Thursday. HIGHLIGHTS * Amphastar Pharmaceuticals Inc AMPH.O : Piper Sandler cuts target price to $66 from $71 * Charles River Laboratories International Inc CRL.N : Baird cuts to neutral * G1 Therapeutics Inc GTHX.O : H.C.
A
A
C
G
A
C
I



स्थितियाँ

लोकप्रिय परिसंपत्तियाँ

अस्वीकरण: XM Group के सत्व केवल निष्पादन वाली सेवा और हमारी ऑनलाइन व्यापार सुविधा में पहुँच प्रदान करते हैं, ताकि व्यक्ति वेबसाइट पर या उसके जरिए उपलब्ध सामग्री को देख सके और/या उसका उपयोग कर सके। इसका प्रयोजन इसे बदलना या विस्तार देना नहीं है, न ही वह इसे बदलता या विस्तार देता है। इस तरह की पहुँच हमेशा ही निम्नलिखित के अधीन रहेगी: (1) नियम और शर्तें; (2) जोखिम चेतावनियाँ; और (3) पूर्ण अस्वीकरण। इसलिए ऐसी जानकारी सामान्य सूचना से अधिक कुछ भी नहीं है। विशेष रूप से, कृपया इससे अवगत रहें कि हमारी ऑनलाइन व्यापार सुविधा की सामग्रियाँ न तो किसी चीज का अनुरोध करती हैं, न ही वित्तीय बाजारों में प्रवेश करने की पेशकश ही करती हैं। किसी भी वित्तीय बाजार में व्यापार करने के साथ आपकी पूँजी को उल्लेखनीय जोखिम है।

हमारी ऑनलाइन व्यापार सुविधा में प्रकाशित सभी सामग्रियाँ शैक्षणिक/सूचनात्मक प्रयोजनों मात्र के लिए हैं, और इनमें वित्तीय, निवेश टैक्स या व्यापार सलाह और सुझाव नहीं हैं - न ही ऐसा समझना चाहिए कि इनमें ये सब हैं; न ही इनमें हमारी व्यापार कीमतों का अभिलेख है; न ही इनमें किसी वित्तीय उपकरण में लेन-देन करने का निमंत्रण या अनुरोध है; न ही ये आपको अवांछित वित्तयी प्रोमोशन पेश करती हैं।

इस वेबसाइट में मौजूद कोई भी तृतीय पक्षीय सामग्री, तथा XM द्वारा तैयार की गई सामग्रियाँ, जैसे: अभिप्राय, समाचार, अनुसंधान, विश्लेषण, कीमतें और अन्य सूचनाएँ या तृतीय पक्षों की साइटों के लिंक, "जैसा-है-वैसा" के आधार पर बाजार के बारे में सामान्य टिप्पणी के रूप में उपलब्ध कराई गई हैं, और वे निवेश हेतु सलाह नहीं हैं। जिस हद तक कीसी सामग्री को निवेश अनुसंधान मान लिया जाता है, उस हद तक आपको ध्यान में रखना होगा और इसे स्वीकार करना होगा कि वह सामग्री इस उद्देश्य से और निवेश अनुसंधान की स्वतंत्रता को बढ़ावा देने के लिए कानूनी आवश्यकताओं के मुताबिक, तैयार नहीं की गई है, और इसलिए उसे प्रासंगिक कानूनों और विनियमों के तहत विपणन संप्रेषण माना जाएगा। कृपया सुनिश्चित करें कि आपने गैर-आश्रित निवेश के बारे में हमारी सूचना को पढ़ और समझ लिया है। पीछे दी गई जानकारी के बारे में अनुसंधान और जोखिम चेतावनी यहाँ उपलब्ध है।

जोखिम की चेतावनी: आपकी पूँजी जोखिम में है। लीवरेज वाले उत्पाद सबके उपयुक्त नहीं होते हैं। कृपया हमारे जोखिम खुलासे पर विचार करें।